Intravenous thrombolysis in acute ischemic stroke after reversal of warfarin anticoagulation in patients with mechanical heart valve prostheses and an INR > 1.7
4 affiliations
- 1Stroke Center, Department of Neurology, Chomutov Hospital, Krajska zdravotni as
- 2Comprehensive Stroke Center, Department of Neurology, Palacký University Medical School and University Hospital Olomouc
- 3Comprehensive Stroke Center, Department of Neurology, Masaryk Hospital, Krajska zdravotni as
- 4Emergency Medical Service of the Usti nad Labem Region
Abstract
Background: Acute ischemic stroke (IS) frequently occurs in patients receiving oral anticoagulant (OAC) therapy. Although warfarin has largely been replaced by direct oral anticoagulants in routine clinical practice, it remains the only approved anticoagulant for certain indications, particularly in patients with mechanical heart valve protstheses. In these patients, the international normalized ratio (INR) is the key determinant of eligibility for intravenous thrombolysis (IVT). We present a potentially effective therapeutic strategy involving rapid reversal of warfarin anticoagulation with four-factor prothrombin complex concentrate (4F-PCC) followed by IVT.
Methods: We report two patients with similar clinical presentations who were receiving long-term warfarin therapy because of a mechanical aortic valve replacement. 76-year-old man with AIS had complete paralysis of the right lower limb, paresis of the right upper limb, and right central facial palsy. INR was 3.2. The second patient was a 76-year-old woman with dysarthria, left central facial palsy and left-sided hemiparesis. Her admission INR was 1.91. In both patients, CT angiography did not demonstrate arterial occlusion suitable for endovascular therapy.
Results: In both patients, four-factor prothrombin complex concentrate (4F-PCC) was administered to achieve rapid normalization of the INR. This was immediately followed by standard IVT. Both patients experienced marked neurological improvement, with no hemorrhagic or thromboembolic complications. At the 3-month follow-up, both had achieved complete functional recovery without residual neurological deficits. In conclusion, it can be stated that the chosen procedure led to an excellent clinical outcome in accordance with previously published cases, in the absence of other standard options for recanalization therapy.
Related
- Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke
- Success rate and determinants of intravenous thrombolysis in acute ischemic stroke from the Malaysia National Stroke Registry
- Machine learning-based models to predict 90-day non-excellent functional outcomes among patients with mild acute ischemic stroke after intravenous thrombolysis
- The C-reactive protein–albumin–lymphocyte (CALLY) index in early hospital presentation and intravenous thrombolysis in acute ischemic stroke : A retrospective study
- Association of the remnant cholesterol inflammation index with long-term outcomes among patients with acute ischemic stroke treated with intravenous thrombolysis
BibTeX
@article{neumann2026intravenous,
title = {{Intravenous thrombolysis in acute ischemic stroke after reversal of warfarin anticoagulation in patients with mechanical heart valve prostheses and an INR > 1.7}},
author = {Jiri Neumann and David Cernik and Jan Bilik},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1937344},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1937344/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Intravenous thrombolysis in acute ischemic stroke after reversal of warfarin anticoagulation in patients with mechanical heart valve prostheses and an INR > 1.7
AU - Jiri Neumann
AU - David Cernik
AU - Jan Bilik
PY - 2026
DA - 2026/10/07
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1937344
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1937344/full
AB - Background: Acute ischemic stroke (IS) frequently occurs in patients receiving oral anticoagulant (OAC) therapy. Although warfarin has largely been replaced by direct oral anticoagulants in routine clinical practice, it remains the only approved anticoagulant for certain indications, particularly in patients with mechanical heart valve protstheses. In these patients, the international normalized ratio (INR) is the key determinant of eligibility for intravenous thrombolysis (IVT). We present a potentially effective therapeutic strategy involving rapid reversal of warfarin anticoagulation with four-factor prothrombin complex concentrate (4F-PCC) followed by IVT. Methods: We report two patients with similar clinical presentations who were receiving long-term warfarin therapy because of a mechanical aortic valve replacement. 76-year-old man with AIS had complete paralysis of the right lower limb, paresis of the right upper limb, and right central facial palsy. INR was 3.2. The second patient was a 76-year-old woman with dysarthria, left central facial palsy and left-sided hemiparesis. Her admission INR was 1.91. In both patients, CT angiography did not demonstrate arterial occlusion suitable for endovascular therapy. Results: In both patients, four-factor prothrombin complex concentrate (4F-PCC) was administered to achieve rapid normalization of the INR. This was immediately followed by standard IVT. Both patients experienced marked neurological improvement, with no hemorrhagic or thromboembolic complications. At the 3-month follow-up, both had achieved complete functional recovery without residual neurological deficits. In conclusion, it can be stated that the chosen procedure led to an excellent clinical outcome in accordance with previously published cases, in the absence of other standard options for recanalization therapy.
SN - 1664-2295
ER -